Peter J. Laud - Concepedia

Author

Peter J. Laud

University of Sheffield ORCID

Also Known As

P J Laud, P Laud, P. J. Laud, P. Laud, P.J. Laud, Pedro M Laud, Peter J Laud, Peter J. Laud, Peter Laud

Publications

Citations

H-Index

Concepts

All Affiliations

University of Sheffield AstraZeneca (United Kingdom)AstraZeneca (United States)Okayama University Hospital Sheffield Teaching Hospitals NHS Foundation Trust

About

Peter J. Laud is an author at University of Sheffield specializing in medicine, antibiotics, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1K
2	Health Sciences	3	3	208
3	Engineering	1	1	28
4	Social Sciences	1	1	102
5	Behavioral Sciences	1	1	102

Peter J. Laud

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial Antoní Torres, Nanshan Zhong, Jan Pachl, The Lancet Infectious Diseases AntibioticsCeftazidime-avibactam Versus MeropenemRespiratory InfectionInfectious Respiratory DiseaseNon-inferiority Trial	2017	427
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study Yehuda Carmeli, J. Armstrong, Peter J. Laud, The Lancet Infectious Diseases Urinary Tract InfectionsUrologyAntimicrobial SusceptibilityAntibioticsBest Available Therapy	2016	399
Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis Daniëlle M. Gerlag, Jasper J. Haringman, Tom Smeets, Arthritis & Rheumatism	2004	154
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension Robert A. Lewis, Christopher Johns, Marcella Cogliano, American Journal of Respiratory and Critical Care Medicine	2019	140
A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia Xinyu Qin, Binh Giang Tran, Min Ja Kim, International Journal of Antimicrobial Agents Intra-abdominal InfectionsPharmacotherapyAntimicrobial ChemotherapyDrug ResistanceAntimicrobial Stewardship	2017	127
Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task John J. Foxe, Kristen P. Morie, Peter J. Laud, Neuropharmacology BiofeedbackSleepCognitive ScienceBehavioral SciencesFatigue Management	2012	102
Transcutaneous Auricular Vagus Nerve Stimulation with Upper Limb Repetitive Task Practice May Improve Sensory Recovery in Chronic Stroke Sheharyar Baig, Konstantinos Falidas, Peter J. Laud, Journal of Stroke and Cerebrovascular Diseases Stimulation DeviceStroke RehabilitationMedicineChronic StrokeNeurological Rehabilitation	2019	53
Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study Jonathan W. Goldman, Marina Chiara Garassino, Yuanbin Chen, Lung Cancer	2020	52
Equal‐tailed confidence intervals for comparison of rates Peter J. Laud Pharmaceutical Statistics	2017	34
Effect of repeated in vivo microCT imaging on the properties of the mouse tibia Sara Oliviero, Mario Giorgi, Peter J. Laud, PLoS ONE EngineeringVivo Micro-computed TomographyMicroscopyAdvanced ImagingVivo Microct	2019	28

Page 1